Patents by Inventor Chi-Chao Chan

Chi-Chao Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240065765
    Abstract: A method of orthopedic treatment includes steps of: by using a computer aided design (CAD) tool based on profile data that is related to a to-be-treated part of a bone of a patient, obtaining a model of a preliminary instrument that substantially fits the to-be-treated part; by using the CAD tool, obtaining a model of a patient specific instrument (PSI) based on the model of the preliminary instrument; producing the PSI based on the model of the PSI, the PSI being adjustable; performing medical operation on the to-be-treated part, and then attaching the PSI to the to-be-treated part; after attaching the PSI to the to-be-treated part, adjusting the PSI such that the PSI is adapted to real conditions of the to-be-treated part.
    Type: Application
    Filed: August 22, 2023
    Publication date: February 29, 2024
    Inventors: Alvin Chao-Yu CHEN, Yi-Sheng CHAN, Chi-Pin HSU, Shang-Chih LIN, Chin-Ju WU, Jeng-Ywan JENG
  • Publication number: 20210040484
    Abstract: Compositions and methods for treating macular degeneration are disclosed. The methods utilize IL17 inhibitors, such as IL17 receptors, as well as fusion proteins including an IL17 receptor fused with a multimerization domain, and recombinant viral vectors encoding such fusions.
    Type: Application
    Filed: March 31, 2020
    Publication date: February 11, 2021
    Inventors: Samuel WADSWORTH, Abraham SCARIA, Chi-Chao CHAN
  • Patent number: 10640771
    Abstract: Compositions and methods for treating macular degeneration are disclosed. The methods utilize IL17 inhibitors, such as IL17 receptors, as well as fusion proteins including an IL17 receptor fused with a multimerization domain, and recombinant viral vectors encoding such fusions.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: May 5, 2020
    Assignees: GENZYME CORPORATION, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE
    Inventors: Samuel Wadsworth, Abraham Scaria, Chi-Chao Chan
  • Publication number: 20160068844
    Abstract: Compositions and methods for treating macular degeneration are disclosed. The methods utilize IL17 inhibitors, such as IL17 receptors, as well as fusion proteins including an IL17 receptor fused with a multimerization domain, and recombinant viral vectors encoding such fusions.
    Type: Application
    Filed: April 17, 2014
    Publication date: March 10, 2016
    Inventors: Samuel WADSWORTH, Abraham SCARIA, Chi-Chao CHAN
  • Publication number: 20140030219
    Abstract: The present invention is directed to methods of diagnosing the presence, severity, or predisposition for development of age-related macular degeneration in a patient based on the frequency of IL-17RC+ cells and or methylation of the promoter of IL17RC gene. Methods of treated age-related macular degeneration are also described.
    Type: Application
    Filed: January 25, 2012
    Publication date: January 30, 2014
    Inventors: Lai Wei, Robert Nussenblatt, Baoying Liu, Chi-chao Chan
  • Patent number: 5597567
    Abstract: The present invention relates, in general, to a method of blocking of cell adhesion molecules. In particular, the present invention relates to a method of blocking cell adhesion molecules with monoclonal antibodies or synthesized substances.
    Type: Grant
    Filed: February 4, 1994
    Date of Patent: January 28, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Scott M. Whitcup, Chi-Chao Chan, Robert B. Nussenblatt